October 5-7, 2016 Boston, MA
PUSH NOVEL DRUGS
TO MARKET BY INNOVATING CLINICAL TRAIL DESIGN, BUILDING NEW ALLIANCES, CULTIVATING EXISTING RELATIONSHIPS, LEVERAGING YOUR DATA AND DISCOVERING NEW TECHNOLOGIES
Pharmaceutical Outsourcing Readers enjoy a 15% discount off our rates when you quote P2100PO
PCT 2016 is back this fall in Boston with the cutting-edge and com- prehensive content you trust, a new intimate format, and reenergized networking. But you have to be there to experience it all for yourself.
HOT TOPICS TO BE COVERED IN 2016 INCLUDE:
• Innovations in Clinical R&D
• Innovative Outsourcing Strategies and Models- Small Biotech’s/Small- Mid Sized Pharma/ Medical Devices
• Risk-Based Approaches in Clinical Development
• Successful Interactions with Regulatory Agencies & Expedited Drug Review/ Approval
• Implementing Disruptive Technologies for Clinical Development
Join us for New Case Studies, Provocative Industry Discussions, Strategic Neworking and Actionable Takeaways:
NEW FOR 2016!
• NEW! OUTSIDE-INDUSTRY KEYNOTES on outsourcing, data analytics, customer service and innovation for fresh insights and best practices to apply to your trials
• NEW! Spotlight Presentation – R&D Challenges in Finding a Cure: Lessons Learned from Running a Clinical Trial for ZIKA
• NEW! INNOVATION PRESENTATIONS – Rapid Fire pitches on cutting-edge innovation and tech to make your trials PRUH FRVW HIIHFWLYH DQG HFLHQW minutes at a time
• NEW! PARTNERING DISCUSSIONS – Find like-minded peers and technologists during focused, niche round table discussions to JGNR [QW QXGTEQOG URGEKƒE EJCNNGPIGU KP your trials
• BACK BY POPULAR DEMAND: WALL STREET KEYNOTE – Looking for Sustainable Business Models in Pharma: The impact of M&A and other Risk-Sharing Trends on Clinical Development
PCT 2016 STATS: 50+
Sessions focused on innovation, technology, small and mid-size pharma, biotechs, and more.
1,100 100+
Clinical Trials Stakeholders from pharma, biotechs, CROs, sites, and more.
Influential Thought Leaders and expert speakers.
Register online at :
www.partnershipsinclinicaltrialsusa.com 2U FDOO XV DW
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54